Specifically, ER+/luminal breast cancer is characterized by a remarkably higher frequency of DNA methylation compared to ER−/basal-like tumors, and a large amount of genes are differentially methylated in different breast cancer subtypes (35, 36). Here, ESR1 is linked to breast carcinoma.